Thuy L. Pham

Daejeon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Neuronal STING-GAT1 signaling maintains paclitaxel-induced neuropathic pain in the spinal cord.

Neuronal STING-GAT1 signaling maintains paclitaxel-induced neuropathic pain in the spinal cord.

Journal: Pain
Published: March 30, 2024

Role of the STING→IRF3 Pathway in Ambient GABA Homeostasis and Cognitive Function.

Role of the STING→IRF3 Pathway in Ambient GABA Homeostasis and Cognitive Function.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: September 24, 2023

Tonic NMDAR Currents of NR2A-Containing NMDARs Represent Altered Ambient Glutamate Concentration in the Supraoptic Nucleus.

Tonic NMDAR Currents of NR2A-Containing NMDARs Represent Altered Ambient Glutamate Concentration in the Supraoptic Nucleus.

Journal: eNeuro
Published: July 26, 2023

Tonic Activation of NR2D-Containing NMDARs Exacerbates Dopaminergic Neuronal Loss in MPTP-Injected Parkinsonian Mice.

Tonic Activation of NR2D-Containing NMDARs Exacerbates Dopaminergic Neuronal Loss in MPTP-Injected Parkinsonian Mice.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: October 17, 2022

MAO-B Inhibitor, KDS2010, Alleviates Spinal Nerve Ligation-induced Neuropathic Pain in Rats Through Competitively Blocking the BDNF/TrkB/NR2B Signaling.

MAO-B Inhibitor, KDS2010, Alleviates Spinal Nerve Ligation-induced Neuropathic Pain in Rats Through Competitively Blocking the BDNF/TrkB/NR2B Signaling.

Journal: The journal of pain
Published: May 10, 2022

Antiallodynic effects of KDS2010, a novel MAO-B inhibitor, via ROS-GABA inhibitory transmission in a paclitaxel-induced tactile hypersensitivity model.

Antiallodynic effects of KDS2010, a novel MAO-B inhibitor, via ROS-GABA inhibitory transmission in a paclitaxel-induced tactile hypersensitivity model.

Journal: Molecular brain
Published: March 28, 2022

Targeting spinal microglia with fexofenadine-loaded nanoparticles prolongs pain relief in a rat model of neuropathic pain.

Targeting spinal microglia with fexofenadine-loaded nanoparticles prolongs pain relief in a rat model of neuropathic pain.

Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: July 22, 2021

Poly(lactic-co-glycolic acid) nanomaterial-based treatment options for pain management: a review.

Poly(lactic-co-glycolic acid) nanomaterial-based treatment options for pain management: a review.

Journal: Nanomedicine (London, England)
Published: August 08, 2020

miRNA 146a-5p-loaded poly(d,l-lactic-co-glycolic acid) nanoparticles impair pain behaviors by inhibiting multiple inflammatory pathways in microglia.

miRNA 146a-5p-loaded poly(d,l-lactic-co-glycolic acid) nanoparticles impair pain behaviors by inhibiting multiple inflammatory pathways in microglia.

Journal: Nanomedicine (London, England)
Published: April 16, 2020

Arginase 2 Deficiency Promotes Neuroinflammation and Pain Behaviors Following Nerve Injury in Mice.

Arginase 2 Deficiency Promotes Neuroinflammation and Pain Behaviors Following Nerve Injury in Mice.

Journal: Journal of clinical medicine
Published: December 20, 2019

Evans Blue Reduces Neuropathic Pain Behavior by Inhibiting Spinal ATP Release.

Evans Blue Reduces Neuropathic Pain Behavior by Inhibiting Spinal ATP Release.

Journal: International journal of molecular sciences
Published: July 23, 2019

Synthesis of Nanoscale Fully Stabilized Zirconia Powders by Urea Hydrolysis, Sintering and Electrical Characterization.

Synthesis of Nanoscale Fully Stabilized Zirconia Powders by Urea Hydrolysis, Sintering and Electrical Characterization.

Journal: Journal of nanoscience and nanotechnology
Published: February 17, 2018
Showing 1-12 of 14

Last Updated: 09/26/2026